XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY INVESTMENT AND ROYALTIES - Schedule of Stock Options, Valuation Assumptions (Details) - Cell MedX Corp. [Member]
3 Months Ended
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk-free rate (%) 0.09%
Expected stock price volatility (%) 135.03%
Expected dividend yield (%) 0.00%
Expected life of options (years) 9 months 29 days